久光製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/03/18 | 3,958 | 4,014 | 3,930 | 3,989 | +88 | +2.3% | 338,200 |
| 2024/03/15 | 3,820 | 3,902 | 3,808 | 3,901 | +73 | +1.9% | 605,600 |
| 2024/03/14 | 3,817 | 3,828 | 3,792 | 3,828 | +28 | +0.7% | 187,300 |
| 2024/03/13 | 3,807 | 3,841 | 3,788 | 3,800 | -19 | -0.5% | 189,700 |
| 2024/03/12 | 3,816 | 3,839 | 3,771 | 3,819 | -2 | -0.1% | 140,200 |
| 2024/03/11 | 3,833 | 3,839 | 3,777 | 3,821 | -21 | -0.5% | 206,700 |
| 2024/03/08 | 3,803 | 3,856 | 3,774 | 3,842 | +37 | +1% | 223,300 |
| 2024/03/07 | 3,805 | 3,824 | 3,779 | 3,805 | +4 | +0.1% | 159,400 |
| 2024/03/06 | 3,781 | 3,841 | 3,780 | 3,801 | +21 | +0.6% | 134,600 |
| 2024/03/05 | 3,813 | 3,826 | 3,762 | 3,780 | -62 | -1.6% | 175,500 |
| 2024/03/04 | 3,870 | 3,884 | 3,833 | 3,842 | -31 | -0.8% | 171,900 |
| 2024/03/01 | 3,874 | 3,913 | 3,862 | 3,873 | -1 | ±0% | 167,900 |
| 2024/02/29 | 3,901 | 3,915 | 3,850 | 3,874 | -44 | -1.1% | 201,200 |
| 2024/02/28 | 3,943 | 3,944 | 3,891 | 3,918 | -79 | -2% | 178,500 |
| 2024/02/27 | 4,025 | 4,037 | 3,978 | 3,997 | -31 | -0.8% | 233,000 |
| 2024/02/26 | 3,994 | 4,050 | 3,970 | 4,028 | +55 | +1.4% | 238,900 |
| 2024/02/22 | 4,000 | 4,014 | 3,958 | 3,973 | -32 | -0.8% | 203,300 |
| 2024/02/21 | 4,042 | 4,042 | 3,981 | 4,005 | -25 | -0.6% | 130,600 |
| 2024/02/20 | 4,036 | 4,055 | 4,020 | 4,030 | ±0 | ±0% | 119,400 |
| 2024/02/19 | 4,036 | 4,052 | 3,998 | 4,030 | -28 | -0.7% | 145,100 |
| 2024/02/16 | 4,024 | 4,076 | 3,997 | 4,058 | +84 | +2.1% | 229,400 |
| 2024/02/15 | 4,097 | 4,097 | 3,958 | 3,974 | -111 | -2.7% | 243,400 |
| 2024/02/14 | 4,130 | 4,132 | 4,040 | 4,085 | -67 | -1.6% | 179,900 |
| 2024/02/13 | 4,150 | 4,162 | 4,098 | 4,152 | +9 | +0.2% | 178,600 |
| 2024/02/09 | 4,106 | 4,162 | 4,085 | 4,143 | +7 | +0.2% | 158,900 |
| 2024/02/08 | 4,153 | 4,158 | 4,102 | 4,136 | -28 | -0.7% | 153,500 |
| 2024/02/07 | 4,150 | 4,172 | 4,132 | 4,164 | ±0 | ±0% | 119,700 |
| 2024/02/06 | 4,206 | 4,206 | 4,158 | 4,164 | -68 | -1.6% | 113,400 |
| 2024/02/05 | 4,213 | 4,244 | 4,194 | 4,232 | +17 | +0.4% | 108,700 |
| 2024/02/02 | 4,209 | 4,225 | 4,189 | 4,215 | +34 | +0.8% | 98,600 |
| 2024/02/01 | 4,191 | 4,207 | 4,161 | 4,181 | -35 | -0.8% | 114,800 |
| 2024/01/31 | 4,168 | 4,220 | 4,159 | 4,216 | +26 | +0.6% | 109,000 |
| 2024/01/30 | 4,252 | 4,252 | 4,190 | 4,190 | -27 | -0.6% | 99,500 |
| 2024/01/29 | 4,211 | 4,234 | 4,196 | 4,217 | +6 | +0.1% | 80,300 |
| 2024/01/26 | 4,193 | 4,240 | 4,191 | 4,211 | +13 | +0.3% | 111,600 |
| 2024/01/25 | 4,190 | 4,213 | 4,161 | 4,198 | -13 | -0.3% | 90,600 |
| 2024/01/24 | 4,201 | 4,228 | 4,167 | 4,211 | +10 | +0.2% | 155,200 |
| 2024/01/23 | 4,217 | 4,260 | 4,181 | 4,201 | -20 | -0.5% | 153,200 |
| 2024/01/22 | 4,147 | 4,225 | 4,125 | 4,221 | +46 | +1.1% | 214,800 |
| 2024/01/19 | 4,250 | 4,262 | 4,147 | 4,175 | -91 | -2.1% | 307,700 |
| 2024/01/18 | 4,301 | 4,325 | 4,266 | 4,266 | -105 | -2.4% | 223,200 |
| 2024/01/17 | 4,365 | 4,450 | 4,360 | 4,371 | -2 | ±0% | 203,900 |
| 2024/01/16 | 4,472 | 4,480 | 4,363 | 4,373 | -107 | -2.4% | 215,500 |
| 2024/01/15 | 4,468 | 4,506 | 4,415 | 4,480 | +34 | +0.8% | 197,700 |
| 2024/01/12 | 4,563 | 4,593 | 4,383 | 4,446 | -116 | -2.5% | 711,000 |
| 2024/01/11 | 4,566 | 4,590 | 4,513 | 4,562 | +56 | +1.2% | 239,600 |
| 2024/01/10 | 4,435 | 4,525 | 4,426 | 4,506 | +104 | +2.4% | 283,000 |
| 2024/01/09 | 4,404 | 4,409 | 4,367 | 4,402 | +49 | +1.1% | 131,100 |
| 2024/01/05 | 4,453 | 4,453 | 4,343 | 4,353 | -60 | -1.4% | 164,000 |
| 2024/01/04 | 4,330 | 4,415 | 4,282 | 4,413 | +102 | +2.4% | 78,100 |
351～
400
件表示中 / 3767件
類似銘柄と比較する
現在ご覧いただいている「久光薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 久光薬 | 428,400円 | +5.8% | +1.2% | 2.80% | 13.87倍 | 1.10倍 |
|
貼る鎮痛消炎剤首位。医療用シェア５割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
| 住友ファーマ | 140,700円 | -11.0% | +206.6% | 0.00% | 13.97倍 | 3.30倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
| 参天薬 | 156,700円 | -2.0% | -7.3% | 2.43% | 15.32倍 | 1.82倍 |
|
緑内障、加齢黄斑変性、ドライアイ治療薬など眼科用医薬品首位。一般用目薬「サンテ」が有名 |
| ツムラ | 361,300円 | +3.8% | -19.9% | 3.76% | 11.74倍 | 0.90倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| 日本新薬 | 322,200円 | +3.6% | -15.3% | 3.85% | 9.05倍 | 0.88倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
市場注目の銘柄
チャート関連のコラム
